Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Surgeons may encounter a higher than expected force to actuate slider mechanism on some xen injectors when they are in the process of implanting the xen 45 gel stent which may lead to ocular trauma especially when surgeon forces slider mechanism forward.